Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Nektar Therapeutics | 4 | 1 | 0 | 0 | 1,13 € | 2,40 € | 112,58 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 53,81 € | 55,00 € | 2,21 % |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | 343,10 € | 418,12 € | 21,87 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 17,75 € | - | - |
| Amicus Therapeutics Inc. | 8 | 0 | 1 | 0 | 10,30 € | 17,63 € | 71,21 % |
| Iovance Biotherapeutics Inc. | 20 | 2 | 1 | 0 | 10,20 € | 26,24 € | 157,22 % |
| Agios Pharmaceuticals Inc. | 9 | 1 | 1 | 0 | 41,20 € | 48,75 € | 18,32 % |
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 1 | 0 | 22,15 € | 55,13 € | 148,91 % |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 2 | 1 | 42,80 € | 56,72 € | 32,53 % |
| Charles River Labs Intl | 13 | 0 | 2 | 0 | 177,20 € | 247,61 € | 39,73 % |
| Exelixis Inc. | 21 | 0 | 3 | 0 | 23,23 € | 26,01 € | 11,95 % |
| PTC Therapeutics Inc. | 15 | 9 | 3 | 0 | 31,20 € | 41,51 € | 33,05 % |
| Xencor Inc. | 16 | 0 | 3 | 0 | 15,20 € | 31,38 € | 106,45 % |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | 51,00 € | 84,74 € | 66,16 % |
| Emergent Biosolutions Inc. | 8 | 2 | 4 | 0 | 8,02 € | 7,44 € | -7,21 % |
| Repligen Corp. | 15 | 0 | 4 | 0 | 130,50 € | 178,01 € | 36,41 % |
| United Therapeutics | 27 | 1 | 5 | 1 | 323,60 € | 332,33 € | 2,70 % |
| Halozyme Therapeutics Inc. | 23 | 0 | 5 | 0 | 58,00 € | 56,47 € | -2,64 % |
| Alnylam Pharmace. | 46 | 0 | 7 | 0 | 252,60 € | 275,15 € | 8,93 % |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | 14,13 € | 29,92 € | 111,79 % |
| Neurocrine Bioscience | 44 | 0 | 9 | 0 | 111,30 € | 149,74 € | 34,53 % |